Programmable multifunctional microrobots for synergistic cuproptosis-immunotherapy
National Science Review · 26.10.2026 · 13 (20)
DOI: 10.1093/nsr/nwag491 ↗Kurz gefasst
Fachartikel in der Zeitschrift National Science Review, online erschienen am 13.08.2026. Verfasst von Chuanhua Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Robotics and Systems, Harbin Institute of Technology, Harbin 150001, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Innovation Project of Shandong Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Oral microrobots as drug carriers have shown great promise in enhancing the therapeutic efficacy of colorectal cancer (CRC). However, existing platforms frequently lack the programmable temporal precision required to execute complex, multistage dosing regimens. Here, we report a programmable temporal-responsive microrobot (PTRM) that autonomously navigates across the gastric acid barrier under external magnetic guidance to execute a sequential drug-release program at orthotopic tumor sites. The PTRM is engineered with a logic-gated architecture, featuring a spatially specific shell for gastric-resistant shielding and exclusive intestinal pH-triggered activation. The system’s internal ‘timer’ is governed by the precise modulation of crosslinking densities within its dual gelatin cores, enabling finely-tuned biphasic release kinetics. Phase 1 executes the programmed release of elesclomol to induce tumor cell cuproptosis, successfully priming the tumor microenvironment by recruiting infiltrating immune cells. Following a precisely tuned 5.5 h interval, Phase 2 triggers the release of PD-1 inhibitors to activate these cells, thereby amplifying immunogenic cell death. This orchestrated sequential cytotoxicity achieved a 76% remission rate in an orthotopic CRC mouse model. Furthermore, the PTRM architecture is highly scalable, accommodating up to six-core configurations for multiphase release—establishing a versatile robotic platform for complex combinatorial therapeutic strategies against recalcitrant cancers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Robotics and Systems, Harbin Institute of Technology, Harbin 150001, China.
- Suzhou Research Institute of HIT, Suzhou 215104, China.
- Key Laboratory of Automotive Power Train and Electronic Control, Hubei University of Automotive Technology, Shiyan 442002, China.
- Department of Oncology Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
- College of Engineering, Ocean University of China, Qingdao 266100, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Förderung
- National Natural Science Foundation of China
- Postdoctoral Innovation Project of Shandong Province
- China Postdoctoral Science Foundation
- Key Technology R&D Program of Shandong Province
- Natural Science Foundation of Heilongjiang Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Li, C., Li, J., Liu, X., Chen, X., Ding, S., Zhao, Y., Luo, X., Li, L., Yang, L., Yu, S., Chang, H., Ji, F., Li, T., & Zhao, J. (2026). Programmable multifunctional microrobots for synergistic cuproptosis-immunotherapy. National Science Review, 13(20). https://doi.org/10.1093/nsr/nwag491
Vancouver
Li C, Li J, Liu X, Chen X, Ding S, Zhao Y, et al. Programmable multifunctional microrobots for synergistic cuproptosis-immunotherapy. National Science Review. 2026;13(20). doi:10.1093/nsr/nwag491
BibTeX
@article{Li2026,
author = {Li, Chuanhua and Li, Jiaxin and Liu, Xuejia and Chen, Xuyang and Ding, Shixiao and Zhao, Yu and Luo, Xiao and Li, Leike and Yang, Laishou and Yu, Shimin and Chang, Hao and Ji, Fengtong and Li, Tianlong and Zhao, Jie},
title = {Programmable multifunctional microrobots for synergistic cuproptosis-immunotherapy},
journal = {National Science Review},
year = {2026},
volume = {13},
number = {20},
doi = {10.1093/nsr/nwag491}
}
EUVIMED